The Healthcare News Diaries
FTC sues main pharmacy benefit managers over insulin prices The agency introduced motion in opposition to Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating tactics “artificially inflated” the record price of lifetime-conserving insulin prescription drugs.Investment in electronic overall health